Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    EIF4G1
Show Display Options
Rank Status Study
1 Unknown  Involvement of Translation Initiation Factors in the Immune Response in the Elderly
Conditions: Elderly Patient;   Infection
2 Completed Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Biological: cixutumumab;   Drug: temsirolimus;   Other: pharmacological study;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years